⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 4, 2024

Supplementary Figure S4 from Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth

Katelyn L. Donahue Hannah R. Watkoske Padma Kadiyala Wenting Du Kristee Brown Michael K. Scales Ahmed M. Elhossiny Carlos E. Espinoza Emily L. Lasse Opsahl Brian D. Griffith Yukang Wen Lei Sun Ashley Velez-Delgado Nur M. Renollet Jacqueline Morales Nicholas M. Nedzesky Rachael K. Baliira Rosa E. Menjivar Paola I. Medina-Cabrera Arvind Rao Benjamin L. Allen Jiaqi Shi Timothy L. Frankel Eileen S. Carpenter Filip Bednar Yaqing Zhang Marina Pasca di Magliano

View at Publisher

Ask AI

Bookmark

Share

Abstract

Figure S4: Loss of stromal IL-33 alters the ST2+ immune cell secretome, resulting in a shift in CAF differentiation.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Donahue et al. (2024) studied this question.

synapsesocial.com/papers/68e55da7e2b3180350efad7c https://doi.org/10.1158/2159-8290.27168824

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S5 from Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth2024
2Supplementary Figure S7 from Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth2024
3Supplementary Figure S3 from Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth2024
4Supplementary Figure S2 from Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth2024
5Supplementary Figure S6 from Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth2024

More related papers

Supplementary Figure S1 from Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth2024
Data from Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth2024
Supplementary Figure S6 from Tumor Cell–Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic Cancer2024